Huffman, Jennifer E. https://orcid.org/0000-0002-9672-2491
Butler-Laporte, Guillaume https://orcid.org/0000-0001-5388-0396
Khan, Atlas https://orcid.org/0000-0002-6651-2725
Pairo-Castineira, Erola
Drivas, Theodore G.
Peloso, Gina M. https://orcid.org/0000-0002-5355-8636
Nakanishi, Tomoko https://orcid.org/0000-0001-9510-5646
,
Ganna, Andrea
Verma, Anurag
Baillie, J. Kenneth https://orcid.org/0000-0001-5258-793X
Kiryluk, Krzysztof
Richards, J. Brent https://orcid.org/0000-0002-3746-9086
Zeberg, Hugo https://orcid.org/0000-0001-7118-1249
Funding for this research was provided by:
Jeanssons Stiftelser
Magnus Bergvalls Stiftelse
NordForsk
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (365825, 409511)
Fonds de Recherche du Québec-Société et Culture
U.S. Department of Health & Human Services | National Institutes of Health (K25DK128563, UL1TR001873, UL1TR001878, UL1TR001873)
Japan Society for the Promotion of Science for Young Scientists
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Smilow family
Canadian Foundation for Innovation Genome Québec The Public Health Agency of Canada The McGill Interdisciplinary Initiative in Infection and Immunity
RCUK | Biotechnology and Biological Sciences Research Council (BBS/E/D/10002070, BBS/E/D/30002275, BBS/E/D/10002070, BBS/E/D/30002275)
Health Data Research UK
Article History
Received: 14 March 2021
Accepted: 29 November 2021
First Online: 13 January 2022
Competing interests
: J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital. His institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this research. He is the founder of 5 Prime Sciences. The other authors declare no competing interests.